Probity Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$509K Sell
20,688
-62
-0.3% -$1.43K 0.07% 162
2026
Q1
$497K Sell
20,750
-330
-2% -$8.07K 0.08% 157
2025
Q4
$477K Sell
21,080
-408
-2% -$8.88K 0.08% 158
2025
Q3
$433K Sell
21,488
-8
-0% -$134 0.07% 168
2025
Q2
$307K Buy
21,496
+6,976
+48% +$81.5K 0.05% 193
2025
Q1
$152K Buy
14,520
+1,314
+10% +$14.9K 0.03% 227
2024
Q4
$160K Buy
+13,206
New +$173K 0.03% 231

Other funds holding ELAN

Probity Advisors's ELAN Position: Q2 2026 in Review

Probity Advisors reduced its Elanco Animal Health (ELAN) stake by 0.3% in Q2 2026, selling an estimated $1.43K and leaving 20,688 shares worth $509K. The position accounts for 0.07% of the portfolio, ranked #162.

Probity Advisors first reported a position in ELAN in Q4 2024 and has held it in 7 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Probity Advisors held 20,688 shares of Elanco Animal Health worth $509K as of Q2 2026.
  • Probity Advisors sold 62 Elanco Animal Health shares in Q2 2026, an estimated $1.43K.
  • Elanco Animal Health made up 0.07% of Probity Advisors's portfolio in Q2 2026, its #162 holding.
  • Probity Advisors first reported a position in Elanco Animal Health in Q4 2024 and has held it in 7 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Probity Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.